1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Muscle Atrophy: new trials by email Literature Review of Muscle Atrophy trials Research Report on Muscle Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit beta-hydroxy-beta-methylbutyrate, Placebo, Vital HP® - Muscle Atrophy | Phase 2 / Phase 3 | Withdrawn | Massachusetts General Hospital | 2017-01-01 | 2021-05-05 |
Critical Illness (1) · Muscular Atrophy (1)
Atrophy (1) · Disease Attributes (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathologic Processes (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
beta-hydroxyisovaleric acid (1)
Massachusetts General Hospital (1)